Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Construction of Mtb۷۲F Plasmid as a DNA Vaccine Candidate for Mycobacterium tuberculosis

Year: 1396
COI: JR_RBMB-6-1_013
Language: EnglishView: 70
This Paper With 7 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 7 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Maryam Sadat Nabavinia - Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Ramezani - Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Aida Gholoobi - Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahboubeh Naderinasab - Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Zahra Meshkat - Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract:

Background:  With one-third of the world’s population infected, tuberculosis (TB) is one of the most common infectious diseases and a major public health problem, especially in developing countries. The efficacy of the BCG vaccine for controlling the disease in adults is poor. The development of an effective TB vaccine is a global objective. An effective tuberculosis vaccine should stimulate cellular immunity. DNA vaccines are a new generation of vaccines with the potential to achieve this goal. The aim of this study was to produce a DNA vaccine of Mtb۷۲F.   Methods: mtb۳۲C, mtb۳۹, and mtb۳۲N were cloned into pcDNA۳.۱ using restriction enzyme digestion and T۴ DNA ligase. Colony-PCR and restriction enzyme digestion were performed to detect transformed bacteria. DNA sequencing confirmed the desired gene insertion into the vector. A Chinese hamster ovary (CHO) cell line was transfected with the recombinant plasmid and RT-PCR was performed to assess gene expression. Results: Gel electrophoresis showed the expected amplified gene fragments of ۴۲۹, ۶۱۴, and ۱۲۰۰ base pairs (bps) for mtb۳۲C, mtb۳۲N, and mtb۳۹, respectively. Enzyme digestion and gel electrophoresis showed the expected fragments, indicating the desired gene position and orientation in the recombinant plasmid. This finding was verified by DNA sequencing, and RT-PCR demonstrated gene expression in the CHO cell line. Conclusions: An Mtb۷۲F DNA plasmid was successfully constructed. This plasmid may be a candidate for animal immunizations.

Keywords:

Paper COI Code

This Paper COI Code is JR_RBMB-6-1_013. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1263044/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Nabavinia, Maryam Sadat and Ramezani, Mohammad and Gholoobi, Aida and Naderinasab, Mahboubeh and Meshkat, Zahra,1396,Construction of Mtb۷۲F Plasmid as a DNA Vaccine Candidate for Mycobacterium tuberculosis,https://civilica.com/doc/1263044

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Organization WH. Global tuberculosis control: epidemiology, strategy, financing: WHO report ...
  • Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, ...
  • Andersen P, Doherty TM. The success and failure of BCG—implications ...
  • Andersen P. Tuberculosis vaccines—an update. Nature Reviews Microbiology. ۲۰۰۷;۵(۷):۴۸۴-۷ ...
  • Lowrie DB, Silva CL, Tascon RE. DNA vaccines against tuberculosis. ...
  • Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, ...
  • Brandt L, Skeiky YA, Alderson MR, Lobet Y, Dalemans W, ...
  • Tsenova L, Harbacheuski R, Moreira AL, Ellison E, Dalemans W, ...
  • Reed SG, Coler RN, Dalemans W, Tan EV, Cruz ECD, ...
  • Spertini F, Audran R, Lurati F, Ofori-Anyinam O, Zysset F, ...
  • Skeiky YA AM, Ovendale PJ, Guderian JA, Brandt L, Dillon ...
  • Dillon DC, Alderson MR, Day CH, Lewinsohn DM, Coler R, ...
  • Skeiky YA, Lodes MJ, Guderian JA, Mohamath R, Bement T, ...
  • Nabavinia MS, Naderi Nasab M, Meshkat Z, Derakhshan M, Khaje-Karamadini ...
  • Nabavinia MS, Nasab MN, Meshkat Z, Derakhshan M, Khaje-Karamadini M. ...
  • Sable SB, Plikaytis BB, Shinnick TM ...
  • Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial ...
  • Thoen C, LoBue P, de Kantor I. The importance of ...
  • Lowrie DB. DNA vaccines for therapy of tuberculosis: where are ...
  • Liang Y, Wu X, Zhang J, Li N, Yu Q, ...
  • Derakhshan M, Safdari H, Sadeghi A, Ghazvini K, Mohammadi S. ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 8,334
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support